A whole recombinant yeast-based therapeutic vaccine elicits HBV X, S and core specific T cells in mice and activates human T cells recognizing epitopes linked to viral clearance

by King T.H., Kemmler C.B., Guo Z., Mann D., Lu Y., Coeshott C., Gehring A.J., Bertoletti A., Ho Z.Z., Delaney W., Gaggar A., Subramanian G.M., McHutchison J.G., Shrivastava S., Lee Y.-J.L., Kottilil S., Bellgrau D., Rodell T., Apelian D.
Published 2018